About Axial Therapeutics
Axial Therapeutics is a private company based in Woburn, Massachusetts. It has reported $109,787,815 raised in seven offerings on Form D since December 2016. Its chief executive is A. Campbell.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 28, 2025 | Feb 11, 2025 | $19,379,799of $22.0M target | 29 | $668K | Equity, OptionsRule 506(b) | Form D ↗ |
| Oct 18, 2023 | Oct 27, 2023 | $11,054,030of $24.0M target | 35 | $315K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| May 11, 2021 | May 26, 2021amended Oct 25, 2021 | $27,352,547of $37.8M target | 38 | $719K | Equity, Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| May 7, 2020 | May 22, 2020 | $7,825,000of $8.0M target | 21 | $372K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 18, 2019 | Jun 24, 2019 | $5,000,000of $10.0M target | 1 | $5.0M | EquityRule 506(b) | Form D ↗ |
| Nov 9, 2018 | Nov 21, 2018 | $20,026,439of $28.0M target | 36 | $556K | EquityRule 506(b) | Form D ↗ |
| Nov 22, 2016 | Dec 7, 2016amended Jun 29, 2017 | $19,150,000fully sold | 16 | $1.1M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, seven offerings | $109,787,815 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Axial Therapeutics's Form D filed Feb 11, 2025.
Earlier filings also listed Sakae Asanuma (director, last listed Oct 2023), Richard Aldrich (director, last listed Oct 2023), Mark Ohori (director, last listed Oct 2023), Jeffrey Young (chief financial officer, last listed Oct 2023), James Blair (director, last listed Oct 2023), Ronald Renaud Jr. (director, last listed Oct 2021), Henry Wolf (director, last listed May 2020) and Eric De La Fortelle (director, last listed May 2020).